SynthesisEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025
A systematic evaluation of clinical practice guidelines for the treatment and management of vestibular schwannoma.
Synthesis in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treatment strategies and survival outcomes of vestibular schwannoma: a comparative study based on Surveillance, Epidemiology, and End Results (SEER) database.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSystematically appraise the quality of clinical practice guidelines (CPGs) for vestibular schwannoma treatment and management by utilizing the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument.
methodsA systematic search of CPGs for the treatment and management of vestibular schwannoma was conducted. MEDLINE (PubMed), EMBASE, and Scopus were queried from inception to January 2023. Inclusion criteria was national and international guidelines or consensus statements. Data was extracted from included articles and four reviewers independently evaluated guidelines in the 6 domains of the AGREE II tool. A domain score was generated with a satisfactory threshold being ≥ 60%.
results785 articles were screened with 9 CPGs selected for evaluation. Three CPGs were found to be "high" quality, five "average" quality, and one "low" quality. CPGs overall scored highest in the "Scope and Purpose" (domain score: 93.67 ± 7.58) and "Clarity and Presentation" (89.04 ± 13.13), while "Applicability" (40.86 ± 25.27) and "Stakeholder Involvement" (57.56 ± 22.08) had the lowest scores. The level of agreement between reviewers was high, with intraclass correlation coefficients ranging from 0.91-0.98 across domains.
conclusionThis appraisal demonstrated an average to high quality for most CPGs regarding vestibular schwannoma treatment and management. While these findings suggest most CPGs are at least average quality, there are opportunities for improvement in several aspects, particularly in domains of applicability, clarifying of conflicts of interest, strength of methodology, and stakeholder involvement.
Indexed as
Identifiers
40782158What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.